Replimune Group (REPL) PT Lowered to $44 at Piper Sandler
Tweet
Share
E-mailGet Alerts REPL Hot Sheet
Price: $14.28 -3.58%
Rating Summary:
10 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 20
Rating Summary:
10 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 20
Join SI Premium – FREE
Piper Sandler analyst Do Kim lowered the price target on Replimune Group (NASDAQ: REPL) to $44.00 (from $52.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Estee Lauder (EL) PT Raised to $112 at JPMorgan
- Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
